Literature DB >> 20495015

Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease.

Fadia Mayyas1, Mark Niebauer, Andrew Zurick, John Barnard, A Marc Gillinov, Mina K Chung, David R Van Wagoner.   

Abstract

BACKGROUND: Atrial fibrillation (AF) promotes atrial remodeling and can develop secondary to heart failure or mitral valve disease. Cardiac endothelin-1 (ET-1) expression responds to wall stress and can promote myocyte hypertrophy and interstitial fibrosis. We tested the hypothesis that atrial ET-1 is elevated in AF and is associated with AF persistence. METHODS AND
RESULTS: Left atrial appendage tissue was studied from coronary artery bypass graft, valve repair, and/or Maze procedure in patients in sinus rhythm with no history of AF (SR, n=21), with history of AF but in SR at surgery (AF/SR, n=23), and in AF at surgery (AF/AF, n=32). The correlation of LA size with atrial protein and mRNA expression of ET-1 and ET-1 receptors (ETAR and ETBR) was evaluated. LA appendage ET-1 content was higher in AF/AF than in SR, but receptor levels were similar. Immunostaining revealed that ET-1 and its receptors were present both in atrial myocytes and in fibroblasts. ET-1 content was positively correlated with LA size, heart failure, AF persistence, and severity of mitral regurgitation. Multivariate analysis confirmed associations of ET-1 with AF, hypertension, and LA size. LA size was associated with ET-1 and MR severity. ET-1 mRNA levels were correlated with genes involved in cardiac dilatation, hypertrophy, and fibrosis.
CONCLUSIONS: Elevated atrial ET-1 content is associated with increased LA size, AF rhythm, hypertension, and heart failure. ET-1 is associated with atrial dilatation, fibrosis, and hypertrophy and probably contributes to AF persistence. Interventions that reduce atrial ET-1 expression and/or block its receptors may slow AF progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495015      PMCID: PMC3050013          DOI: 10.1161/CIRCEP.109.924985

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  32 in total

1.  Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP.

Authors:  K Yamashita; D J Discher; J Hu; N H Bishopric; K A Webster
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

2.  The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure.

Authors:  C P Cheng; T Ukai; K Onishi; N Ohte; M Suzuki; Z S Zhang; H J Cheng; H Tachibana; A Igawa; W C Little
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-04       Impact factor: 4.733

3.  Relation of left atrial pathology to atrial fibrillation in mitral valvular disease.

Authors:  G W Bailey; B A Braniff; E W Hancock; K E Cohn
Journal:  Ann Intern Med       Date:  1968-07       Impact factor: 25.391

4.  Endothelin system in human persistent and paroxysmal atrial fibrillation.

Authors:  B J Brundel; I C Van Gelder; A E Tuinenburg; M Wietses; D J Van Veldhuisen; W H Van Gilst; H J Crijns; R H Henning
Journal:  J Cardiovasc Electrophysiol       Date:  2001-07

Review 5.  The human heart endothelin system: ET-1 synthesis, storage, release and effect.

Authors:  F D Russell; P Molenaar
Journal:  Trends Pharmacol Sci       Date:  2000-09       Impact factor: 14.819

6.  Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.

Authors:  Eva Gerdts; Lasse Oikarinen; Vittorio Palmieri; Jan Erik Otterstad; Kristian Wachtell; Kurt Boman; Björn Dahlöf; Richard B Devereux
Journal:  Hypertension       Date:  2002-03-01       Impact factor: 10.190

7.  Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome.

Authors:  Francesco Grigioni; Jean-François Avierinos; Lieng H Ling; Christopher G Scott; Kent R Bailey; A Jamil Tajik; Robert L Frye; Maurice Enriquez-Sarano
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

8.  N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Authors:  Kristen K Patton; Patrick T Ellinor; Susan R Heckbert; Robert H Christenson; Christopher DeFilippi; John S Gottdiener; Richard A Kronmal
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

9.  Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice.

Authors:  Li L Yang; Robert Gros; M Golam Kabir; Almuktafi Sadi; Avrum I Gotlieb; Mansoor Husain; Duncan J Stewart
Journal:  Circulation       Date:  2004-01-12       Impact factor: 29.690

Review 10.  Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.

Authors:  Oussama M Wazni; David O Martin; Nassir F Marrouche; Ahmed Abdel Latif; Khaled Ziada; Mustaphasahim Shaaraoui; Soufian Almahameed; Robert A Schweikert; Walid I Saliba; A Marc Gillinov; W H Wilson Tang; Roger M Mills; Gary S Francis; James B Young; Andrea Natale
Journal:  Circulation       Date:  2004-06-21       Impact factor: 29.690

View more
  47 in total

Review 1.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

2.  Etiology, Pathology, and Classification of Atrial Fibrillation.

Authors:  Srishti Nayak; Balaji Natarajan; Ramdas G Pai
Journal:  Int J Angiol       Date:  2020-03-29

Review 3.  Alterations in atrial perfusion during atrial fibrillation.

Authors:  Christina F Pacchia; Derek J Dosdall; Ravi Ranjan; Edward DiBella
Journal:  Exp Physiol       Date:  2014-07-25       Impact factor: 2.969

4.  Is Left Atrial Size a Predictor of Mortality after Coronary Artery Bypass Surgery? A Single Center Study.

Authors:  Khalid S Ibrahim; Fadia A Mayyas; Khalid Kheirallah; Nizar R AlWaqfi; David R Van Wagoner
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

5.  A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block.

Authors:  David Alvarez; Paraskevi Briassouli; Robert M Clancy; Jiri Zavadil; Joanne H Reed; Rosanna G Abellar; Marc Halushka; Karen Fox-Talbot; Franck J Barrat; Jill P Buyon
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

6.  American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association.

Authors:  N A Mark Estes; Ralph L Sacco; Sana M Al-Khatib; Patrick T Ellinor; Judy Bezanson; Alvaro Alonso; Charles Antzelevitch; Randall G Brockman; Peng-Sheng Chen; Sumeet S Chugh; Anne B Curtis; John P DiMarco; Kenneth A Ellenbogen; Andrew E Epstein; Michael D Ezekowitz; Pierre Fayad; Brian F Gage; Alan S Go; Mark A Hlatky; Elaine M Hylek; Michael Jerosch-Herold; Marvin A Konstam; Richard Lee; Douglas L Packer; Sunny S Po; Eric N Prystowsky; Susan Redline; Yves Rosenberg; David R Van Wagoner; Kathryn A Wood; Lixia Yue; Emelia J Benjamin
Journal:  Circulation       Date:  2011-06-27       Impact factor: 29.690

Review 7.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

8.  Left atrial dilatation in systolic heart failure: a marker of poor prognosis, not just a buffer between the left ventricle and pulmonary circulation.

Authors:  A Rossi; F L Dini; E Agricola; P Faggiano; G Benfari; P L Temporelli; C Cucco; L Scelsi; C Vassanelli; S Ghio
Journal:  J Echocardiogr       Date:  2018-02-23

9.  Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation.

Authors:  Jordi Heijman; Dorit Kirchner; Franziska Kunze; Eva Maria Chrétien; Martina B Michel-Reher; Niels Voigt; Michael Knaut; Martin C Michel; Ursula Ravens; Dobromir Dobrev
Journal:  Int J Cardiol       Date:  2017-12-22       Impact factor: 4.164

10.  Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model.

Authors:  Fadia Mayyas; Seiichiro Sakurai; Rashmi Ram; Julie H Rennison; Eui-Seock Hwang; Laurie Castel; Beth Lovano; Marie-Luise Brennan; Douglas Bibus; Bill Lands; John Barnard; Mina K Chung; David R Van Wagoner
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.